<code id='576D77829A'></code><style id='576D77829A'></style>
    • <acronym id='576D77829A'></acronym>
      <center id='576D77829A'><center id='576D77829A'><tfoot id='576D77829A'></tfoot></center><abbr id='576D77829A'><dir id='576D77829A'><tfoot id='576D77829A'></tfoot><noframes id='576D77829A'>

    • <optgroup id='576D77829A'><strike id='576D77829A'><sup id='576D77829A'></sup></strike><code id='576D77829A'></code></optgroup>
        1. <b id='576D77829A'><label id='576D77829A'><select id='576D77829A'><dt id='576D77829A'><span id='576D77829A'></span></dt></select></label></b><u id='576D77829A'></u>
          <i id='576D77829A'><strike id='576D77829A'><tt id='576D77829A'><pre id='576D77829A'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:focus    Page View:768
          People taking notes while sitting around a meeting table
          Adobe

          It makes sense in theory for hospitals and startups to strike deals. Not only would doctors get first dibs on new health care technologies, their organizations would see windfalls if those startups hit it big.

          In practice, it often doesn’t work out that way. Doctors and other clinicians have their own way of doing things, and they typically don’t take kindly to an administrator telling them to learn a new product, especially if the goal is financial gain.

          advertisement

          Several health system-venture capital arrangements have fallen victim to this dynamic — but VC firm General Catalyst said this week it will buy nonprofit Summa Health, anyway.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Medicare details structure of new drug price negotiation program
          Medicare details structure of new drug price negotiation program

          MedicareonFridayreleasednewdetailsabouthowitsnewdrugpricenegotiationprogramwillwork,justtwomonthsbef

          read more
          GSK to buy asthma
          GSK to buy asthma

          AdobeLONDON—GSKsaidTuesdayitwouldpurchasetheasthma-focuseddrugdeveloperAiolosBiofor$1billionupfront,

          read more
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban
          The Supreme Court will review a ruling striking down a domestic violence federal gun ban

          WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

          read more

          Tesla recalling nearly 16,000 of its 2021

          FILE-TheTeslacompanylogoisshownataTesladealershipinLittleton,Colo.Feb.2,2020.Teslasaidinitssafetyrec